{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:50:09Z","timestamp":1783003809990,"version":"3.54.5"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00f8retak","doi-asserted-by":"publisher","award":["912129"],"award-info":[{"award-number":["912129"]}],"id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00f8retak","doi-asserted-by":"publisher","award":["912043"],"award-info":[{"award-number":["912043"]}],"id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Bergen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fatigue is common in patients with chronic inflammatory and autoimmune diseases, often with a severe impact on the patient\u2019s daily life. From a biological point of view, fatigue can be regarded as an element of the sickness behavior response, a coordinated set of responses induced by pathogens to enhance survival during an infection and immunological danger. The mechanisms are not fully understood but involve activation of the innate immune system, with pro-inflammatory cytokines, in particular interleukin (IL)-1\u03b2, acting on cerebral neurons. These mechanisms are also active during chronic inflammatory conditions. High mobility group box 1 (HMGB1) protein has interleukin-1 like properties and is a strong inducer of innate immune responses. Its role in generation of fatigue is not clarified. Emerging evidence indicates that also other biomolecules may influence sickness behavior. We aimed to elucidate how HMGB1 influences fatigue in patients with Crohn\u2019s disease, and how the protein interacts with other candidate biomarkers of fatigue.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In 56 patients with newly diagnosed Crohn\u2019s disease, fatigue was evaluated using three different fatigue instruments: the fatigue visual analog scale (fVAS), Fatigue Severity Scale (FSS), and the vitality subscale of Medical Outcomes Study Short-Form Health Survey (SF-36vs). The biochemical markers IL-1 receptor antagonist (RA), soluble IL-1 receptor type 2 (sIL-RII), heat shock protein 90 alpha (HSP90\u03b1), HMGB1, anti-fully reduced (fr)HMGB1 antibodies (abs), hemopexin (HPX), and pigment epithelium-derived factor (PEDF) were measured in plasma. Multivariable regression and principal component analyses (PCA) were applied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Multivariable regression analyses revealed significant contributions to fatigue severity for HMGB1 in the FSS model, HSP90\u03b1 in the fVAS model and IL-1RA in the SF-36vs model. Depression and pain scores contributed to all three models. In PCA, two components described 53.3% of the variation. The \u201cinflammation and cellular stress dimension\u201d was dominated by IL-1RA, sIL-1RII, HSP90\u03b1, HPX, and PEDF scores, where the \u201cHMGB1 dimension\u201d was dominated by HMGB1, anti-frHMGB1 abs, and fVAS scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study supports the hypothesis that HMGB1 and a network of other biomolecules influence fatigue severity in chronic inflammatory conditions. The well-known association with depression and pain is also acknowledged.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-023-00679-6","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T11:02:25Z","timestamp":1687777345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["High mobility group box 1 and a network of other biomolecules influence fatigue in patients with Crohn\u2019s disease"],"prefix":"10.1186","volume":"29","author":[{"given":"Ingeborg","family":"Kvivik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"Grimstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil","family":"B\u00e5rdsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grete","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Terje","family":"Kval\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6051-4658","authenticated-orcid":false,"given":"Roald","family":"Omdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"679_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.smim.2018.02.011","volume":"38","author":"U Andersson","year":"2018","unstructured":"Andersson U, Yang H, Harris H. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells. Semin Immunol. 2018;38:40\u20138.","journal-title":"Semin Immunol"},{"issue":"2","key":"679_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/0961203318817826","volume":"28","author":"DR Azizoddin","year":"2019","unstructured":"Azizoddin DR, Gandhi N, Weinberg S, Sengupta M, Nicassio PM, Jolly M. Fatigue in systemic lupus: the role of disease activity and its correlates. Lupus. 2019;28(2):163\u201373.","journal-title":"Lupus"},{"key":"679_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2377-5-22","volume":"5","author":"JN Baraniuk","year":"2005","unstructured":"Baraniuk JN, Casado B, Maibach H, Clauw DJ, Pannell LK, Hess SS. A Chronic Fatigue Syndrome\u2014related proteome in human cerebrospinal fluid. BMC Neurol. 2005;5:22.","journal-title":"BMC Neurol"},{"issue":"3","key":"679_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1753425916633236","volume":"22","author":"K B\u00e5rdsen","year":"2016","unstructured":"B\u00e5rdsen K, Nilsen MM, Kval\u00f8y JT, Norheim KB, Jonsson G, Omdal R. Heat shock proteins and chronic fatigue in primary Sjogren\u2019s syndrome. Innate Immun. 2016;22(3):162\u20137.","journal-title":"Innate Immun"},{"issue":"1","key":"679_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12974-019-1502-8","volume":"16","author":"K B\u00e5rdsen","year":"2019","unstructured":"B\u00e5rdsen K, Brede C, Kvivik I, Kval\u00f8y JT, Jonsdottir K, Tjensvoll AB, et al. Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sj\u00f6gren\u2019s syndrome. J Neuroinflammation. 2019;16(1):102.","journal-title":"J Neuroinflammation"},{"issue":"9573","key":"679_CR6","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369(9573):1641\u201357.","journal-title":"Lancet"},{"issue":"2","key":"679_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69\u201377.","journal-title":"J Psychosom Res"},{"issue":"11\u201312","key":"679_CR8","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1080\/10715762.2019.1697809","volume":"53","author":"N Brook","year":"2019","unstructured":"Brook N, Brook E, Dharmarajan A, Chan A, Dass CR. The role of pigment epithelium-derived factor in protecting against cellular stress. Free Radic Res. 2019;53(11\u201312):1166\u201380.","journal-title":"Free Radic Res"},{"key":"679_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fimmu.2016.00159","volume":"7","author":"SK Calderwood","year":"2016","unstructured":"Calderwood SK, Gong J, Murshid A. Extracellular HSPs: the complicated roles of extracellular HSPs in immunity. Front Immunol. 2016;7:159.","journal-title":"Front Immunol"},{"issue":"10","key":"679_CR10","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1196","volume":"34","author":"C Cavelti-Weder","year":"2011","unstructured":"Cavelti-Weder C, Furrer R, Keller C, Babians-Brunner A, Solinger AM, Gast H, et al. Inhibition of IL-1\u03b2 improves fatigue in type 2 diabetes. Diabetes Care. 2011;34(10): e158.","journal-title":"Diabetes Care"},{"issue":"1","key":"679_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46\u201356.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"679_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tins.2013.10.003","volume":"37","author":"R Dantzer","year":"2014","unstructured":"Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L. The neuroimmune basis of fatigue. Trends Neurosci. 2014;37(1):39\u201346.","journal-title":"Trends Neurosci"},{"issue":"4","key":"679_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","volume":"60","author":"M Daperno","year":"2004","unstructured":"Daperno M, D\u2019Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD. Gastrointest Endosc. 2004;60(4):505\u201312.","journal-title":"Gastrointest Endosc"},{"issue":"14","key":"679_CR14","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117(14):3720\u201332.","journal-title":"Blood"},{"issue":"4","key":"679_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/npp.2011.285","volume":"37","author":"C Ditzen","year":"2012","unstructured":"Ditzen C, Tang N, Jastorff AM, Teplytska L, Yassouridis A, Maccarrone G, et al. Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology. 2012;37(4):1013\u201325.","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"679_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/acps.12656","volume":"134","author":"P Ellul","year":"2016","unstructured":"Ellul P, Boyer L, Groc L, Leboyer M, Fond G. Interleukin-1\u03b2-targeted treatment strategies in inflammatory depression: toward personalized care. Acta Psychiatr Scand. 2016;134(6):469\u201384.","journal-title":"Acta Psychiatr Scand"},{"issue":"12","key":"679_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.185","volume":"5","author":"MA Frye","year":"2015","unstructured":"Frye MA, Nassan M, Jenkins GD, Kung S, Veldic M, Palmer BA, et al. Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders. Transl Psychiatry. 2015;5(12): e689.","journal-title":"Transl Psychiatry"},{"issue":"10","key":"679_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","volume":"3","author":"S Gardella","year":"2002","unstructured":"Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002;3(10):995\u20131001.","journal-title":"EMBO Rep"},{"issue":"2","key":"679_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4049\/jimmunol.2000014","volume":"205","author":"Y Geng","year":"2020","unstructured":"Geng Y, Munirathinam G, Palani S, Ross JE, Wang B, Chen A, et al. HMGB1-neutralizing igm antibody is a normal component of blood plasma. J Immunol. 2020;205(2):407\u201313.","journal-title":"J Immunol"},{"issue":"5","key":"679_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12026-022-09295-8","volume":"70","author":"D Ghosh","year":"2022","unstructured":"Ghosh D, Singh A, Kumar A, Sinha N. High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice. Immunol Res. 2022;70(5):633\u201343.","journal-title":"Immunol Res"},{"issue":"7","key":"679_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.mp.4002055","volume":"13","author":"I Goshen","year":"2008","unstructured":"Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry. 2008;13(7):717\u201328.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"679_CR22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ecco-jcc\/jjv091","volume":"9","author":"T Grimstad","year":"2015","unstructured":"Grimstad T, Norheim KB, Isaksen K, Leitao K, Hetta AK, Carlsen A, et al. Fatigue in newly diagnosed inflammatory bowel disease. J Crohn\u2019s Colitis. 2015;9(9):725\u201330.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"2","key":"679_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/1753425919879988","volume":"26","author":"T Grimstad","year":"2020","unstructured":"Grimstad T, Kvivik I, Kval\u00f8y JT, Aabakken L, Omdal R. Heat-shock protein 90\u03b1 in plasma reflects severity of fatigue in patients with Crohn\u2019s disease. Innate Immun. 2020;26(2):146\u201351.","journal-title":"Innate Immun"},{"issue":"3","key":"679_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/00365521.2021.2007281","volume":"57","author":"T Grimstad","year":"2022","unstructured":"Grimstad T, Skjellerudsveen BM, Kval\u00f8y JT, Skoie IM, Carlsen A, Karlsen LN, et al. The influence of disease activity on fatigue in patients with ulcerative colitis\u2014a longitudinal study. Scand J Gastroenterol. 2022;57(3):290\u20137.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"679_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/acr2.11379","volume":"4","author":"HB Hammer","year":"2022","unstructured":"Hammer HB, Agular B, Terslev L. Fatigue is not associated with objective assessments of inflammation during tocilizumab treatment of patients with rheumatoid arthritis. ACR Open Rheumatol. 2022;4(3):202\u20138.","journal-title":"ACR Open Rheumatol"},{"issue":"8","key":"679_CR26","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.bbi.2009.06.151","volume":"23","author":"E Harboe","year":"2009","unstructured":"Harboe E, Tjensvoll AB, Vefring HK, G\u00f8ransson LG, Kval\u00f8y JT, Omdal R. Fatigue in primary Sj\u00f6gren\u2019s syndrome\u2013a link to sickness behaviour in animals? Brain Behav Immun. 2009;23(8):1104\u20138.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"679_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","volume":"12","author":"BL Hart","year":"1988","unstructured":"Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12(2):123\u201337.","journal-title":"Neurosci Biobehav Rev"},{"issue":"8167","key":"679_CR28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM. A simple index of Crohn\u2019s-disease activity. Lancet. 1980;1(8167):514.","journal-title":"Lancet"},{"key":"679_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s10020-018-0023-8","volume":"24","author":"M He","year":"2018","unstructured":"He M, Bianchi ME, Coleman TR, Tracey KJ, Al-Abed Y. Exploring the biological functional mechanism of the HMGB1\/TLR4\/MD-2 complex by surface plasmon resonance. Mol Med. 2018;24:21.","journal-title":"Mol Med"},{"issue":"1","key":"679_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/jnnp.2005.065805","volume":"77","author":"C Heesen","year":"2006","unstructured":"Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry. 2006;77(1):34\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"679_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/ane.12977","volume":"138","author":"K Herlofson","year":"2018","unstructured":"Herlofson K, Heijnen CJ, Lange J, Alves G, Tysnes OB, Friedman JH, et al. Inflammation and fatigue in early, untreated Parkinson\u2019s Disease. Acta Neurol Scand. 2018;138(5):394\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 11","key":"679_CR32","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1002\/acr.20579","volume":"63","author":"S Hewlett","year":"2011","unstructured":"Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS). Arthritis Care Res (hoboken). 2011;63(Suppl 11):S263\u201386.","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"3","key":"679_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060388","volume":"8","author":"DJ Hines","year":"2013","unstructured":"Hines DJ, Choi HB, Hines RM, Phillips AG, MacVicar BA. Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides. PLoS ONE. 2013;8(3): e60388.","journal-title":"PLoS ONE"},{"issue":"3","key":"679_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nrn.2018.2","volume":"19","author":"K Inoue","year":"2018","unstructured":"Inoue K, Tsuda M. Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential. Nat Rev Neurosci. 2018;19(3):138\u201352.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"679_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0960-5428(96)00014-9","volume":"6","author":"LB Krupp","year":"1996","unstructured":"Krupp LB, Pollina D. Neuroimmune and neuropsychiatric aspects of chronic fatigue syndrome. Adv Neuroimmunol. 1996;6(2):155\u201367.","journal-title":"Adv Neuroimmunol"},{"issue":"4","key":"679_CR36","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/17534259211014252","volume":"27","author":"I Kvivik","year":"2021","unstructured":"Kvivik I, Grimstad T, Jonsson G, Kval\u00f8y JT, Omdal R. Anti-HMGB1 auto-Abs influence fatigue in patients with Crohn\u2019s disease. Innate Immun. 2021;27(4):286\u201393.","journal-title":"Innate Immun"},{"issue":"31","key":"679_CR37","doi-asserted-by":"publisher","first-page":"12728","DOI":"10.1073\/pnas.1118748109","volume":"109","author":"J Lampa","year":"2012","unstructured":"Lampa J, Westman M, Kadetoff D, Agreus AN, Le Maitre E, Gillis-Haegerstrand C, et al. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. Proc Natl Acad Sci U S A. 2012;109(31):12728\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"679_CR38","doi-asserted-by":"crossref","unstructured":"Larssen E, Brede C, Hjelle A, Tjensvoll AB, Norheim KB, B\u00e5rdsen K, et al. Fatigue in primary Sj\u00f6gren\u2019s syndrome: a proteomic pilot study of cerebrospinal fluid. SAGE Open Med. 2019;7.","DOI":"10.1177\/2050312119850390"},{"issue":"2","key":"679_CR39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144\u201364.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"679_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8674(00)80412-2","volume":"91","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov R, Janeway CA. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 1997;91(3):295\u20138.","journal-title":"Cell"},{"issue":"6","key":"679_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105413","volume":"89","author":"L Miglianico","year":"2022","unstructured":"Miglianico L, Cornec D, Devauchelle-Pensec V, Berrouiguet S, Walter M, Nabbe P, et al. Identifying clinical, biological, and quality of life variables associated with depression, anxiety, and fatigue in pSS and sicca syndrome patients: a prospective single-centre cohort study. Joint Bone Spine. 2022;89(6): 105413.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"679_CR42","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/WCO.0000000000000817","volume":"33","author":"R Omdal","year":"2020","unstructured":"Omdal R. The biological basis of chronic fatigue: neuroinflammation and innate immunity. Curr Opin Neurol. 2020;33(3):391\u20136.","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"679_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10067-015-3035-6","volume":"35","author":"CL Overman","year":"2016","unstructured":"Overman CL, Kool MB, Da Silva JA, Geenen R. The prevalence of severe fatigue in rheumatic diseases: an international study. Clin Rheumatol. 2016;35(2):409\u201315.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"679_CR44","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/rheumatology\/kel021","volume":"45","author":"LC Pollard","year":"2006","unstructured":"Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (oxford). 2006;45(7):885\u20139.","journal-title":"Rheumatology (oxford)"},{"key":"679_CR45","doi-asserted-by":"crossref","unstructured":"Pope JE. Management of fatigue in rheumatoid arthritis. RMD Open. 2020;6(1).","DOI":"10.1136\/rmdopen-2019-001084"},{"issue":"1","key":"679_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12974-017-0796-7","volume":"14","author":"ME Roerink","year":"2017","unstructured":"Roerink ME, van der Schaaf ME, Dinarello CA, Knoop H, van der Meer JW. Interleukin-1 as a mediator of fatigue in disease: a narrative review. J Neuroinflammation. 2017;14(1):16.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"679_CR47","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/ibd.21285","volume":"16","author":"MJ Romberg-Camps","year":"2010","unstructured":"Romberg-Camps MJ, Bol Y, Dagnelie PC, Hesselink-van de Kruijs MA, Kester AD, Engels LG, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis. 2010;16(12):2137\u201347.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"679_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.51","volume":"7","author":"KM Ryan","year":"2017","unstructured":"Ryan KM, Glaviano A, O\u2019Donovan SM, Kolshus E, Dunne R, Kavanagh A, et al. Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study. Transl Psychiatry. 2017;7(3): e1073.","journal-title":"Transl Psychiatry"},{"issue":"1\u20132","key":"679_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neulet.2005.01.035","volume":"380","author":"T Sanagi","year":"2005","unstructured":"Sanagi T, Yabe T, Yamada H. The regulation of pro-inflammatory gene expression induced by pigment epithelium-derived factor in rat cultured microglial cells. Neurosci Lett. 2005;380(1\u20132):105\u201310.","journal-title":"Neurosci Lett"},{"issue":"1","key":"679_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2011.09.003","volume":"72","author":"A Sanchez","year":"2012","unstructured":"Sanchez A, Tripathy D, Yin X, Luo J, Martinez J, Grammas P. Pigment epithelium-derived factor (PEDF) protects cortical neurons in vitro from oxidant injury by activation of extracellular signal-regulated kinase (ERK) 1\/2 and induction of Bcl-2. Neurosci Res. 2012;72(1):1\u20138.","journal-title":"Neurosci Res"},{"issue":"3","key":"679_CR51","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1084\/jem.20111739","volume":"209","author":"M Schiraldi","year":"2012","unstructured":"Schiraldi M, Raucci A, Munoz LM, Livoti E, Celona B, Venereau E, et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med. 2012;209(3):551\u201363.","journal-title":"J Exp Med"},{"issue":"1","key":"679_CR52","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1038\/s41598-022-11802-8","volume":"12","author":"BM Skjellerudsveen","year":"2022","unstructured":"Skjellerudsveen BM, Omdal R, Hetta AK, Kval\u00f8y JT, Aabakken L, Skoie IM, et al. Fatigue: a frequent and biologically based phenomenon in newly diagnosed celiac disease. Sci Rep. 2022;12(1):7281.","journal-title":"Sci Rep"},{"issue":"2","key":"679_CR53","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/bjd.15375","volume":"177","author":"IM Skoie","year":"2017","unstructured":"Skoie IM, Dalen I, Ternowitz T, Jonsson G, Kvivik I, Norheim K, et al. Fatigue in psoriasis: a controlled study. Br J Dermatol. 2017;177(2):505\u201312.","journal-title":"Br J Dermatol"},{"issue":"6","key":"679_CR54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.immuni.2009.03.020","volume":"30","author":"DE Smith","year":"2009","unstructured":"Smith DE, Lipsky BP, Russell C, Ketchem RR, Kirchner J, Hensley K, et al. A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. Immunity. 2009;30(6):817\u201331.","journal-title":"Immunity"},{"issue":"9","key":"679_CR55","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00535-012-0566-3","volume":"47","author":"H Takaishi","year":"2012","unstructured":"Takaishi H, Kanai T, Nakazawa A, Sugata F, Nikai A, Yoshizawa S, et al. Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1\/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype. J Gastroenterol. 2012;47(9):969\u201377.","journal-title":"J Gastroenterol"},{"key":"679_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109792","volume":"98","author":"T Tian","year":"2020","unstructured":"Tian T, Yang Y, Xu B, Qin Y, Zang G, Zhou C, et al. Pigment epithelium-derived factor alleviates depressive-like behaviors in mice by modulating adult hippocampal synaptic growth and Wnt pathway. Prog Neuropsychopharmacol Biol Psychiatry. 2020;98: 109792.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"679_CR57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/104454902753759717","volume":"21","author":"E Tolosano","year":"2002","unstructured":"Tolosano E, Altruda F. Hemopexin: structure, function, and regulation. DNA Cell Biol. 2002;21(4):297\u2013306.","journal-title":"DNA Cell Biol"},{"issue":"8","key":"679_CR58","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrn1176","volume":"4","author":"J Tombran-Tink","year":"2003","unstructured":"Tombran-Tink J, Barnstable CJ. PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci. 2003;4(8):628\u201336.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"679_CR59","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1182\/blood.V90.3.1101.1101_1101_1108","volume":"90","author":"M van Deuren","year":"1997","unstructured":"van Deuren M, van der Ven-Jongekrijg J, Vannier E, van Dalen R, Pesman G, Bartelink AK, et al. The pattern of interleukin-1\u03b2(IL-1\u03b2) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood. 1997;90(3):1101\u20138.","journal-title":"Blood"},{"issue":"5425","key":"679_CR60","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248\u201351.","journal-title":"Science"},{"issue":"10","key":"679_CR61","first-page":"1896","volume":"31","author":"F Wolfe","year":"2004","unstructured":"Wolfe F. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. J Rheumatol. 2004;31(10):1896\u2013902.","journal-title":"J Rheumatol"},{"issue":"3","key":"679_CR62","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/glia.20171","volume":"50","author":"T Yabe","year":"2005","unstructured":"Yabe T, Sanagi T, Schwartz JP, Yamada H. Pigment epithelium-derived factor induces pro-inflammatory genes in neonatal astrocytes through activation of NF-kappa B and CREB. Glia. 2005;50(3):223\u201334.","journal-title":"Glia"},{"issue":"26","key":"679_CR63","doi-asserted-by":"publisher","first-page":"11942","DOI":"10.1073\/pnas.1003893107","volume":"107","author":"H Yang","year":"2010","unstructured":"Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci. 2010;107(26):11942\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"679_CR64","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/labinvest.2013.66","volume":"93","author":"Z Yang","year":"2013","unstructured":"Yang Z, Deng Y, Su D, Tian J, Gao Y, He Z, et al. TLR4 as receptor for HMGB1-mediated acute lung injury after liver ischemia\/reperfusion injury. Lab Invest. 2013;93(7):792\u2013800.","journal-title":"Lab Invest"},{"issue":"2","key":"679_CR65","first-page":"91","volume":"9","author":"T Yokoyama","year":"1998","unstructured":"Yokoyama T, Oda M, Seino Y. Interleukin-1\u03b2 and interleukin-1 receptor antagonist levels in cerebrospinal fluid of aseptic meningitis patients. Pediatr Allergy Immunol. 1998;9(2):91\u20136.","journal-title":"Pediatr Allergy Immunol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00679-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-023-00679-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00679-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T11:05:38Z","timestamp":1687777538000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-023-00679-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1186\/s10020-023-00679-6","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"6 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out in compliance with the principles outlined in the Helsinki Declaration and approved by the Norwegian Regional Ethics Committee (REK 2011\/2631). All participants provided written informed consent to participate in the study. The study was registered at ClinicalTrials.gov (NCT01551563).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}